Please wait a minute...
文章检索
预防医学  2020, Vol. 32 Issue (2): 147-151    DOI: 10.19485/j.cnki.issn2096-5087.2020.02.010
  综述 本期目录 | 过刊浏览 | 高级检索 |
同型半胱氨酸与妊娠相关疾病研究进展
陈冬琳1,2(综述), 徐键3(审校)
1. 浙江大学医学院,浙江 杭州 310000;
2. 金华市妇幼保健院;
3. 浙江大学医学院附属第四医院
Research progress of homocysteine and pregnancy-related diseases
CHEN Donglin*, XU Jian
*Zhejiang University School of Medicine,Hangzhou,Zhejiang 310000,China
全文: PDF(722 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 高同型半胱氨酸血症(HHcy)已被公认为是心脑血管疾病的危险因子,参与疾病的发生发展。近年研究发现同型半胱氨酸(Hcy)水平升高与复发性流产、妊娠高血压和妊娠糖尿病等妊娠相关疾病的发生发展及辅助生殖技术成功率关系密切,并作为其可控因素受到关注。本文对Hcy与妊娠相关疾病的相关研究进行综述,为Hcy致病机制研究和妊娠期疾病防治提供依据。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
陈冬琳
徐键
关键词 同型半胱氨酸复发性流产妊娠高血压妊娠糖尿病    
Abstract:Hyperhomocysteinemia has been recognized as a risk factor for cardiovascular and cerebrovascular diseases,which is involved in the occurrence and development of the diseases. It has been found recently that the increase of homocysteine is closely related to recurrent pregnancy loss,gestational hypertension,gestational diabetes mellitus and the success rate of assisted reproductive technology. Homocysteine is concerned as a controllable factor for pregnancy-associated diseases. This article reviews the studies into the relationship between homocysteine and pregnancy-associated diseases,so as to provide evidence for future research on pathogenesis and prognosis of pregnancy-associated diseases.
Key wordshomocysteine    recurrent pregnancy loss    gestational hypertension    gestational diabetes mellitus
收稿日期: 2019-09-23      修回日期: 2019-11-20     
中图分类号:  R714.2  
作者简介: 徐键,E-mail:15057982260@163.com
引用本文:   
陈冬琳, 徐键. 同型半胱氨酸与妊娠相关疾病研究进展[J]. 预防医学, 2020, 32(2): 147-151.
CHEN Donglin, XU Jian. Research progress of homocysteine and pregnancy-related diseases. Preventive Medicine, 2020, 32(2): 147-151.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2020.02.010      或      http://www.zjyfyxzz.com/CN/Y2020/V32/I2/147
[1] MASCARENHAS M,HABEEBULLAH S,SRIDHAR M G.Revisiting the role of first trimester homocysteine as an index of maternal and fetal outcome[J]. J Pregnancy,2014:1-6.
[2] 黄娟娟,张利平,张娟,等. 多囊卵巢综合征不孕患者卵泡液同型半胱氨酸水平检测及与葡萄糖、雌二醇水平的相关性探讨[J]. 检验医学,2018,33(1):88-90.
[3] 周登诗,黄芳,范大志,等. 同型半胱氨酸、叶酸和维生素B12水平与不良妊娠结局的相关性分析[J]. 中国计划生育学杂志,2017,25(9):624-626
[4] YANG Y,JIANG H,TANG A,et al.Changes of serum homocysteine levels during pregnancy and the establishment of reference intervals in pregnant Chinese women[J]. Clin Chim Acta,2019,489:1-4.
[5] 骆婵珍,万波,吴瑕,等. 正常妊娠妇女血清同型半胱氨酸水平调查[J]. 检验医学,2014,29(7):723-726.
[6] SEREMAK-MROZIKIEWICZ A,BOGACZ A,BARTKOWIAK- WIECZOREK J,et al.The importance of MTHFR,MTR,MTRR and CSE expression levels in Caucasian women with preeclampsia[J]. Eur J Obstet Gynecol Reprod Biol,2015,188:113-117.
[7] 邢金芳,贾莉婷,荣守华,等. 育龄女性叶酸代谢关键酶基因多态性与维生素B12和同型半胱氨酸关系的研究[J]. 中国妇幼保健,2014,29(21):3498-3501.
[8] 赵峰,李建平,王淑玉,等. 高血压人群基线同型半胱氨酸水平对依那普利叶酸片降压及降同型半胱氨酸疗效的分析[J]. 中华医学杂志,2009,88(42):2957-2961.
[9] 曹露,娄晓盈,牟娜娜,等.叶酸抑制同型半胱氨酸诱导的人肾脏系膜细胞增殖[J]. 成都医学院学报,2013,8(2):43-46.
[10] WOUTERS M G,BOERS G H,BLOM H J,et al.Hyperhomocysteinemia:a risk factor in women with unexplained recurrent early pregnancy loss[J]. Fertil Steril,1993,60(5):820-825.
[11] NASIRI M,ARSANJANI-SHIRAZI A,SADEGHI O,et al.The relationship between homocysteine levels and spontaneous abortion in Iranian women with migraine[J]. Iran J Public Health,2017,46(8):1149-1151.
[12] KAMALI M,HANTOUSHZADEH S,BORNA S,et al.Association between thrombophilic genes polymorphisms and recurrent pregnancy loss susceptibility in the Iranian population:a systematic review and meta-analysis[J]. Iran Biomed J,2018,22(2):78-89.
[13] GAIDAY A N,TUSSUPKALIYEV A B,BERMAGAMBETOVA S K,et al.Effect of homocysteine on pregnancy:a systematic review[J]. Chem Biol Interact,2018,293:70-76.
[14] BOYAMA B A,CEPNI I,IMAMOGLU M,et al.Homocysteine in embryo culture media as a predictor of pregnancy outcome in assisted reproductive technology[J]. Gynecol Endocrinol,2016,32(3):193-195.
[15] 马春艺,路阳,苏赛,等. 高同型半胱氨酸与复发性流产的相关性研究[J]. 中国妇幼卫生杂志,2014,5(5):20-22.
[16] RAH H,CHUNG K W,KO K H,et al.MiR-27a and miR-449b polymorphisms associated with a risk of idiopathic recurrent pregnancy loss[J]. PLoS One,2017,12(5):e0177160.
[17] CHEN H,YANG X,LU M .Methylenetetrahydrofolate reductase gene polymorphisms and recurrent pregnancy loss in China:a systematic review and meta-analysis[J]. Arch Gynecol Obstet,2016,293(2):283-290.
[18] 丁宁薇. 亚甲基四氢叶酸还原酶基因677位多态性、高同型半胱氨酸血症与复发性流产[J]. 世界最新医学信息文摘,2019, 19(31):121-125.
[19] JASLOW C R,CARNEY J L,KUTTEH W H.Diagnostic factors identified in 1 020 women with two versus three or more recurrent pregnancy losses[J]. Fertil Steril,2010,93(4):1234-1243.
[20] 谢幸,孔北华,段涛.妇产科学[M]. 9版. 北京:人民卫生出版社,2018:84-85.
[21] 李盼,李建权,赵红艳,等. 同型半胱氨酸与妊娠期高血压的研究现状[J]. 当代医学,2018,24(34):197-200.
[22] CAN M,GUVEN B,BEKTAS S,et al.Oxidative stress and apoptosis in preeclampsia[J]. Tissue Cell,2014,46(6):477-481.
[23] 许雅娟,洪腾,翟闪闪,等. 血清叶酸、同型半胱氨酸与妊娠期高血压疾病相关性研究[J]. 安徽医科大学学报,2018,53(9):161-163.
[24] 沈卫,方娴静,唐志慧,等. 同型半胱氨酸水平与妊娠期糖尿病、高血压的相关性验证研究[J]. 名医,2018(3):74,129.
[25] MAGED A M,SAAD H,MESHAAL H,et al.Maternal serum homocysteine and uterine artery Doppler as predictors of preeclampsia and poor placentation[J]. Arch Gynecol Obstet,2017,296(3):475-482.
[26] MASOURA S,KALOGIANNIDIS I A,GITAS G,et al.Biomarkers in preeclampsia:a novel approach to early detection of the disease[J]. J Obstet Gynaecol,2012,32(7):609-616.
[27] MARU L,VERMA M,JINSIWLE N.Homocysteine as predictive marker for pregnancy-induced hypertension-a comparative study of homocysteine levels in normal versus patients of PIH and its complications[J]. J Obstet Gynaecol India,2016,66(Suppl.1):167-171.
[28] 王艳辉,刘艳平,卢淑丽. 不良妊娠结局影响因素分析[J]. 预防医学,2018,30(3):303-305.
[29] THOMAS V,SHAHNAZ R,SHIPENG Y,et al.Matrix metalloproteinases in atherosclerosis:role of nitric oxide,hydrogen sulfide,homocysteine,and polymorphisms[J]. Vasc Health Risk Manag,2015,27(11):173-183.
[30] 王森. 二甲双胍对肥胖2型糖尿病患者抵抗素、胰岛素样生长因子I及炎性因子的影响[J]. 海南医学院学报,2016,22(2):154-156.
[31] QIU C,SORENSEN T K,LUTHY D A,et al.A prospective study of maternal serum C-reactive protein(CRP)concentrations and risk of gestational diabetes mellitus[J]. Paediatr Perinat Epidemiol,2010,18(5):377-384.
[32] GUVEN M A,CETINKAYA A.Elevated plasma homocysteine levels in gestational diabetes mellitus[J]. Acta Obstet Gynecol Scand,2005,84(3):306-307.
[33] GONG T,WANG J,YANG M,et al.Serum homocysteine level and gestational diabetes mellitus:a meta-analysis[J]. J Diabetes Investig,2016,7(4):622-628.
[34] 于婷婷,卢旺娣,孙青阳,等. 正常人群同型半胱氨酸水平及相关因素分析[J]. 预防医学,2017,29(3):248-250.
[35] BEDAIWY M A,FALCONE T,MOHAMED M S,et al.Differential growth of human embryos in vitro:role of reactive oxygen species[J]. Fertil Steril,2004,82(3):593-600.
[36] 刘红林,孟繁星,氧化应激对动物有腔卵泡闭锁的影响及机制[J]. 南京农业大学学报,2019,42(1):6-13.
[37] HUANG X,QIN X,YANG W,et al.MTHFR gene and serum folate interaction on serum homocysteine lowering:prospect for precision folic acid treatment[J]. Arterioscler Thromb Vasc Biol,2018,38(3):679-685.
[38] TEIXEIRA J A,STELUTI J,GORGULHO B M,et al.Prudent dietary pattern influences homocysteine level more than folate,vitamin B12,and docosahexaenoic acid:a structural equation model approach[J]. Eur J Nutr,2019:1-11.
[39] 王淑贞,杜建国,刘杰,等. 叶酸对妊娠期糖尿病患者血清同型半胱氨酸、游离脂肪酸的影响及其相关性研究[J].中国卫生检验杂志,2019,29(8):974-976
[40] 张雪梅. 高血同型半胱氨酸血症人群的健康教育效果评价[J]. 现代医学与健康研究,2018,2(2):125.
[41] WANG Y H,YAN Q H,XU Y J,et al.High prevalence and factors contributing to hyperhomocysteinemia,folate deficiency,and vitamin B12 deficiency among healthy adults in Shanghai,China[J]. Biomed Environ Sci,2019,32(1):63-67.
[1] 马奕竹, 赵效国, 朱启英, 马依拉·买买提, 张环美, 苑晓琳, 李莉. 孕期膳食模式与妊娠糖尿病的关联研究[J]. 预防医学, 2023, 35(4): 286-290.
[2] 谢睿, 胡菊莲, 喻喆. 妊娠糖尿病患者生活质量的影响因素研究[J]. 预防医学, 2023, 35(2): 162-165.
[3] 李娜娜, 张师静, 陈巧敏, 栗浩然, 王雅莉. 孕前体质指数与妊娠糖尿病的剂量-反应关系[J]. 预防医学, 2023, 35(10): 829-833.
[4] 蓝仙梅, 罗霞, 郑晓红, 周小燕. 丽水市单胎活产儿早产的影响因素分析[J]. 预防医学, 2021, 33(3): 313-316.
[5] 舒铭铭, 潘兴强, 张百蕾, 黄芳, 张婧, 洪菱, 蔡婕. 被动吸烟与妊娠糖尿病的关联分析[J]. 预防医学, 2020, 32(7): 726-729.
[6] 任艳军, 刘庆敏, 刘冰, 张艳, 赵刚, 丁华. 2009—2018年杭州市妊娠糖尿病发病趋势[J]. 预防医学, 2020, 32(3): 244-247.
[7] 陈颖, 陈莉莉, 徐晓红, 黄珍珍, 娄增谦. 丽水市孕妇血清维生素水平分析[J]. 预防医学, 2020, 32(2): 184-186.
[8] 史美琦, 郑钜圣, 付元庆, 卢莎, 汪旭虹, 胡文胜. 妊娠糖尿病孕妇血清25-(OH)D水平与代谢性指标的相关性研究[J]. 预防医学, 2020, 32(10): 1069-1071.
[9] 朱蔚, 胡健伟, 冯佩, 喻茜, 刘丽. 血清尾加压素水平与妊娠高血压的关系研究[J]. 预防医学, 2020, 32(1): 68-70.
[10] 杨延平, 刘晓红, 朱建良, 胡志勇, 季巧英. 丽水市职业人群同型半胱氨酸水平分析[J]. 预防医学, 2020, 32(1): 80-82.
[11] 张芝银, 李秀央, 郑国英, 黄晶, 周红. 不良妊娠结局的影响因素分析[J]. 预防医学, 2020, 32(1): 94-97.
[12] 王丽君, 甘培元, 何丽雅, 陆怡, 何文芳, 徐泽汝, 郭君平, 华燕吟. 妊娠中期糖脂代谢水平与妊娠结局的相关性分析[J]. 预防医学, 2018, 30(8): 762-765,770.
[13] 何丹妮,李萍,魏红霞. 妊娠高血压改良风险预警评估管理效果观察[J]. 预防医学, 2018, 30(6): 639-641.
[14] 吕惠娟, 张玉梅, 阮丹, 陈海玲. 妊娠高血压孕妇信息动机行为技巧模型干预效果评价[J]. 预防医学, 2018, 30(11): 1183-1185.
[15] 王雁, 王伯忠, 项巧珍, 周建妹, 赵力, 任爱华. 高强度运动对高同型半胱氨酸血症大鼠抗氧化和内皮功能的影响[J]. 预防医学, 2017, 29(6): 550-554.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed